Omni Bio Pharmaceutical (OMBP) Short Interest Ratio & Short Volume $0.0010 0.00 (0.00%) As of 08/18/2020 Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Omni Bio Pharmaceutical Short Interest DataOmni Bio Pharmaceutical (OMBP) has a short interest of 700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest700 sharesPrevious Short Interest700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.70Short Interest Ratio1.2 Days to CoverLast Record DateAugust 14, 2020Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Omni Bio Pharmaceutical? Sign up to receive the latest short interest report for Omni Bio Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMBP Short Interest Over TimeOMBP Days to Cover Over TimeOMBP Percentage of Float Shorted Over Time Omni Bio Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/14/2020700 shares $0.70 No ChangeN/A1.2 $0.00 7/31/2020700 shares $17.50 No ChangeN/A0 $0.03 OMBP Short Interest - Frequently Asked Questions What is Omni Bio Pharmaceutical's current short interest? Short interest is the volume of Omni Bio Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of August 14th, investors have sold 700 shares of OMBP short. Learn More on Omni Bio Pharmaceutical's current short interest. What is a good short interest ratio for Omni Bio Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMBP shares currently have a short interest ratio of 1.0. Learn More on Omni Bio Pharmaceutical's short interest ratio. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.88 billion), Aon plc ($3.14 billion), The Clorox Company ($2.93 billion), The Charles Schwab Corporation ($2.69 billion), Moderna, Inc. ($2.19 billion), The Kroger Co. ($2.09 billion), Simon Property Group, Inc. ($1.87 billion), International Flavors & Fragrances Inc. ($1.71 billion), Iron Mountain Incorporated ($1.64 billion), and Snap Inc. ($1.59 billion). View all of the most shorted stocks. What does it mean to sell short Omni Bio Pharmaceutical stock? Short selling OMBP is an investing strategy that aims to generate trading profit from Omni Bio Pharmaceutical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Omni Bio Pharmaceutical? A short squeeze for Omni Bio Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMBP, which in turn drives the price of the stock up even further. How often is Omni Bio Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMBP, twice per month. The most recent reporting period available is August, 14 2020. More Short Interest Resources from MarketBeat Related Companies 4Front Ventures Short Squeeze Algernon Pharmaceuticals Short Squeeze Allstar Health Brands Short Squeeze Alvotech Short Squeeze American Bio Medica Short Squeeze American Oriental Bioengineering Short Squeeze Anthera Pharmaceuticals Short Squeeze AstraZeneca Short Squeeze AVVAA World Health Care Products Short Squeeze AXIM Biotechnologies Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:OMBP) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omni Bio Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omni Bio Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.